Your browser doesn't support javascript.
loading
Personalized Comments on Challenges and Opportunities in Kidney Disease Therapeutics: The Glom-NExT Symposium.
Greka, Anna; Gibson, Deb; Mundel, Peter; Demetri, George; Hildebrandt, Friedhelm; Pollak, Martin; Florez, Jose.
Afiliação
  • Greka A; Department of Medicine and Glom-NExT Center for Glomerular Kidney Disease and Novel Experimental Therapeutics, Renal Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Broad Institute of Massachusetts Institute of Technology, and Harvard, Cambridge, MA. Electronic address
  • Gibson D; Department of Pediatrics, University of Michigan School of Medicine, Ann Arbor, MI.
  • Mundel P; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • Demetri G; Dana Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Hildebrandt F; Department of Medicine, Division of Nephrology, Children's Hospital and Harvard Medical School, Boston, MA.
  • Pollak M; Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.
  • Florez J; Broad Institute of Massachusetts Institute of Technology, and Harvard, Cambridge, MA; Center for Human Genetic Research and Diabetes Research Center, Diabetes Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Semin Nephrol ; 36(6): 448, 2016 11.
Article em En | MEDLINE | ID: mdl-27987543
In the face of ever-increasing incidence and prevalence of kidney disease worldwide, the unmet need for new treatments is unprecedented. Precision medicine is defined as the use of modern technologies to identify mechanisms of diseases in individual patients, and thus deploy treatment using tailored, targeted approaches, in the hopes of avoiding unnecessary toxicities and complications. Is there a place for kidney disease therapeutics in this space? If so, what is required to make significant progress toward precision nephrology? To answer these critical questions, we present a series of personalized comments corresponding to the responses offered to these very questions during the Inaugural Glom-NExT Symposium held at Harvard Medical School on October 23, 2014, a national meeting focused exclusively on kidney disease therapeutics.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicina de Precisão / Nefropatias Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicina de Precisão / Nefropatias Idioma: En Ano de publicação: 2016 Tipo de documento: Article